In the study presented here, we conducted the first comprehensive analysis of how the combination of the two FDA-approved drugs, metformin and L-asparaginase, impacts DLBCL cell metabolism and survival, both in cellulo and in vivo. The gene discussed is ASPG; the disease is diffuse large B-cell lymphoma.